Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Azitra Inc (AZTR)

Azitra Inc (AZTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,109
  • Shares Outstanding, K 7,626
  • Annual Sales, $ 690 K
  • Annual Income, $ -11,280 K
  • EBIT $ -10 M
  • EBITDA $ -9 M
  • 60-Month Beta -1.33
  • Price/Sales 4.54
  • Price/Cash Flow N/A
  • Price/Book 0.39
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -12.04
  • Most Recent Earnings $-0.17 on 11/12/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.51
  • Number of Estimates 1
  • High Estimate -0.51
  • Low Estimate -0.51
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3803 +16.59%
on 12/18/24
0.5271 -15.88%
on 11/29/24
-0.0760 (-14.63%)
since 11/27/24
3-Month
0.3803 +16.59%
on 12/18/24
0.6340 -30.06%
on 10/21/24
-0.1066 (-19.38%)
since 09/27/24
52-Week
0.3803 +16.59%
on 12/18/24
68.4000 -99.35%
on 01/18/24
-35.5566 (-98.77%)
since 12/27/23

Most Recent Stories

More News
Top 5 Biotech Stocks That Captured Retail Investor Interest The Most In 2024

Despite their stock price struggles, these companies have captivated retail investors with groundbreaking therapies and promising clinical developments.

CERO : 0.0595 (-0.83%)
NKGN : 0.7301 (-16.47%)
IMRX : 2.31 (+5.96%)
AZTR : 0.4401 (+7.95%)
PBM : 2.27 (-5.02%)
Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates

/PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision...

AZTR : 0.4401 (+7.95%)
Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors

/PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision...

AZTR : 0.4401 (+7.95%)
Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer

/PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision...

AZTR : 0.4401 (+7.95%)
Azitra, Inc. Announces Closing of Initial Public Offering

/PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR) (the "Company"), a biopharmaceutical company focused on developing innovative therapies for precision...

AZTR : 0.4401 (+7.95%)
Azitra, Inc. Announces Pricing of Initial Public Offering

/PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR) (the "Company"), a biopharmaceutical company focused on developing innovative therapies for precision...

AZTR : 0.4401 (+7.95%)

Business Summary

Azitra Inc. is an early-stage clinical biopharmaceutical company. It focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. Azitra Inc. is based in BRANFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 0.4399
2nd Resistance Point 0.4284
1st Resistance Point 0.4181
Last Price 0.4401
1st Support Level 0.3963
2nd Support Level 0.3848
3rd Support Level 0.3745

See More

52-Week High 68.4000
Fibonacci 61.8% 42.4165
Fibonacci 50% 34.3902
Fibonacci 38.2% 26.3638
Last Price 0.4401
52-Week Low 0.3803

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar